Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about OXIDATIVE_STRESS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
OXIDATIVE_STRESS is a concept in neurodegeneration research. Key relationships include: causes, inhibits, activates. Associated with CVD, NEURODEGENERATION, PARKINSON_DISEASE. Connected to 46 entities in the SciDEX knowledge graph.
AI-generated illustration · click image to enlarge
Regenerate portrait ↻| Name | OXIDATIVE_STRESS |
| Key Genes/Proteins | AKT, ASK1, BAK1, BAX, BID, CA2 |
| Related Diseases | CARDIAC_AGING, CELLULAR_SENESCENCE, CVD |
| Related Pathways | AUTOPHAGY, CA2_HOMEOSTASIS |
Knowledge base pages for this entity
graph TD
OXIDATIVE_STRESS["OXIDATIVE_STRESS"]
OXIDATIVE_STRESS -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
OXIDATIVE_STRESS -->|"causes"| hemolysis["hemolysis"]
OXIDATIVE_STRESS -->|"causes"| OxPCs["OxPCs"]
OXIDATIVE_STRESS -->|"inhibits"| CA2_HOMEOSTASIS["CA2_HOMEOSTASIS"]
OXIDATIVE_STRESS -->|"causes"| STRESS_GRANULES["STRESS_GRANULES"]
OXIDATIVE_STRESS -->|"causes"| DNA_DAMAGE["DNA_DAMAGE"]
OXIDATIVE_STRESS -->|"causes"| FERROPTOSIS["FERROPTOSIS"]
OXIDATIVE_STRESS -->|"regulates"| CA2["CA2"]
OXIDATIVE_STRESS -->|"regulates"| calcium["calcium"]
OXIDATIVE_STRESS -->|"causes"| intestinal_barrier["intestinal_barrier"]
NRF2["NRF2"] -->|"regulates"| OXIDATIVE_STRESS
HSPA1A["HSPA1A"] -->|"inhibits"| OXIDATIVE_STRESS
hydrogen_peroxide["hydrogen_peroxide"] -->|"causes"| OXIDATIVE_STRESS
ROS["ROS"] -->|"causes"| OXIDATIVE_STRESS
SIRT1["SIRT1"] -->|"inhibits"| OXIDATIVE_STRESS
SIRT3["SIRT3"] -->|"inhibits"| OXIDATIVE_STRESS
METHYLENE_BLUE["METHYLENE_BLUE"] -->|"inhibits"| OXIDATIVE_STRESS
curcumin["curcumin"] -->|"inhibits"| OXIDATIVE_STRESS
GPS["GPS"] -->|"inhibits"| OXIDATIVE_STRESS| Target | Relation | Type | Str |
|---|---|---|---|
| sepsis-associated encephalopathy | contributes_to | unknown | 0.95 |
| alzheimers | implicated_in | disease | 0.95 |
| Parkinson's disease | implicated_in | unknown | 0.95 |
| protein aggregation | causes | mechanism | 0.90 |
| mitochondrial_dysfunction | associated_with | mechanism | 0.90 |
| neuroinflammation | causes | mechanism | 0.90 |
| microglial_activation | causes | mechanism | 0.90 |
| ASK1 | activates | protein | 0.90 |
| APOPTOSIS | associated_with | process | 0.90 |
| NEURODEGENERATION | activates | disease | 0.87 |
| mitochondrial_dysfunction | modulates | mechanism | 0.85 |
| Parkinson's disease | involved_in | unknown | 0.85 |
| neurological dysfunction | causes | unknown | 0.85 |
| alzheimer_disease | involved_in | disease | 0.85 |
| protein aggregation | contributes_to | mechanism | 0.85 |
| neuroinflammation | associated_with | mechanism | 0.85 |
| lysophosphatidylcholine | correlates_with | unknown | 0.85 |
| neuronal death | contributes_to | unknown | 0.85 |
| lysophosphatidylethanolamine | correlates_with | unknown | 0.85 |
| microglial_activation | associated_with | mechanism | 0.80 |
| NEURON | causes | cell_type | 0.80 |
| mitochondrial_transfer | inhibits | mechanism | 0.80 |
| mitochondrial_dysfunction | causes | mechanism | 0.80 |
| alzheimers | contributes_to | disease | 0.80 |
| cognitive dysfunction | causes | unknown | 0.80 |
| mitochondrial_dysfunction | contributes_to | mechanism | 0.80 |
| Parkinson's disease | contributes_to | unknown | 0.80 |
| microglial_activation | activates | mechanism | 0.75 |
| microglial_activation | contributes_to | mechanism | 0.75 |
| alpha_synuclein_aggregation | contributes_to | mechanism | 0.75 |
| alzheimer_disease | contributes_to | disease | 0.75 |
| TDP-43_aggregation | contributes_to | phenotype | 0.75 |
| ischemic_injury | contributes_to | unknown | 0.75 |
| neuroinflammation | contributes_to | mechanism | 0.75 |
| alzheimer_disease | associated_with | disease | 0.75 |
| glymphatic_clearance | associated_with | mechanism | 0.75 |
| blood-brain barrier permeability | associated_with | unknown | 0.75 |
| alzheimers | associated_with | disease | 0.75 |
| Parkinson's disease | associated_with | unknown | 0.75 |
| aging | associated_with | unknown | 0.75 |
| hemolysis | causes | phenotype | 0.72 |
| OxPCs | causes | protein | 0.72 |
| CA2 | regulates | protein | 0.72 |
| CA2_HOMEOSTASIS | inhibits | pathway | 0.72 |
| STRESS_GRANULES | causes | phenotype | 0.72 |
| DNA_DAMAGE | causes | phenotype | 0.72 |
| FERROPTOSIS | causes | phenotype | 0.72 |
| glymphatic_clearance | inhibits | mechanism | 0.70 |
| GCase | inhibits | protein | 0.70 |
| protein_aggregation | associated_with | mechanism | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| iron mismanagement | causes | unknown | 0.95 |
| lipid_droplet_biogenesis | causes | pathway | 0.90 |
| microglial_activation | causes | mechanism | 0.90 |
| iron | causes | unknown | 0.90 |
| iron accumulation | causes | mechanism | 0.90 |
| Cytokines | causes | protein | 0.90 |
| loss of iron homeostasis | associated_with | unknown | 0.90 |
| HSP70 | biomarker_for | protein | 0.85 |
| intermittent_fasting | modulates | unknown | 0.85 |
| alzheimer_disease | associated_with | disease | 0.85 |
| AMPK | inhibits | unknown | 0.85 |
| mitochondrial_transfer | contributes_to | mechanism | 0.85 |
| GCase | causes | protein | 0.85 |
| TNF | associated_with | protein | 0.85 |
| HK2 | modulates | protein | 0.85 |
| mitochondrial_transfer | modulates | mechanism | 0.82 |
| microglial_activation | increases_risk | mechanism | 0.80 |
| GCase | associated_with | protein | 0.80 |
| neurodegeneration | associated_with | disease | 0.80 |
| protein aggregation | associated_with | mechanism | 0.80 |
| adolescent alcohol consumption | causes | unknown | 0.80 |
| insulin_resistance | contributes_to | unknown | 0.80 |
| beta-amyloid | causes | unknown | 0.80 |
| APOE4 | contributes_to | protein | 0.80 |
| microglial_activation | contributes_to | mechanism | 0.80 |
| sleep_deprivation | causes | phenotype | 0.80 |
| NNMT | causes | gene | 0.80 |
| NRF2 | regulates | protein | 0.79 |
| HSP70 | mediates | protein | 0.78 |
| Edaravone | treats | drug | 0.78 |
| GPR32 | modulates | protein | 0.78 |
| ferroptosis | associated_with | mechanism | 0.75 |
| GCase | modulates | protein | 0.75 |
| Tau | associated_with | unknown | 0.75 |
| TREM1 | modulates | unknown | 0.75 |
| mitochondrial_transfer | associated_with | mechanism | 0.75 |
| HK2 | associated_with | protein | 0.75 |
| APOE4 | associated_with | protein | 0.75 |
| AKT | involved_in | gene | 0.75 |
| microglial_activation | mediates | mechanism | 0.75 |
| PI3K | involved_in | gene | 0.75 |
| SIRT3 | inhibits | gene | 0.72 |
| hydrogen_peroxide | causes | drug | 0.72 |
| G6PD_deficiency | associated_with | disease | 0.72 |
| ROS | causes | phenotype | 0.72 |
| SIRT1 | inhibits | gene | 0.72 |
| HSPA1A | inhibits | gene | 0.72 |
| AQP4 | associated_with | protein | 0.72 |
| FOXO1 | modulates | gene | 0.70 |
| TFEB | modulates | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| FOXO3-Pioneer Factor Complex Stabilizes Heterochromatin Unde | 0.700 | neurodegeneration | Investigate mechanisms of epigenetic rep |
| NRF2-Mediated Proteostatic Convergence: Shared Oxidative Str | 0.700 | neurodegeneration | - |
| Amyloid-beta induces secondary pericyte senescence after con | 0.640 | neurodegeneration | Does pericyte senescence drive BBB break |
| NRF2 Activation to Counteract Oxidative Stress from RGS6 Def | 0.518 | neurodegeneration | Does RGS6 upregulation or D2 autorecepto |
| XOR+ stress-responsive astrocytes represent a novel AD-assoc | 0.380 | Alzheimer's disease | - |
| Astrocyte-specific autophagy deficiency induces NADPH oxidas | 0.380 | ALS | How do non-cell autonomous effects of au |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| In midlife, lower Aβ42:Aβ40 ratio was associated with increased risk o | clinical | Alzheimer's disease | 0.500 | 0.00 | human | extracted | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning OXIDATIVE_STRESS in their description or question text